What is Renvela (sevelamer) 800 mg used for?
Renvela is the brand name for sevelamer, a medicine used to treat high phosphate levels (hyperphosphatemia) in people with chronic kidney disease (CKD). It binds phosphate in the gut so the body absorbs less of it, lowering blood phosphate levels.
In practice, Renvela is prescribed for people who have CKD and need help controlling phosphate, including those who are on dialysis and those not yet on dialysis.
How do doctors use Renvela in dialysis vs. non-dialysis CKD?
The main “use” stays the same—lower blood phosphate—but the treatment context differs:
- Dialysis patients: Renvela is used as part of the overall CKD-mineral and bone disorder (CKD-MBD) plan to control serum phosphate.
- Non-dialysis CKD: Renvela can also be used to manage elevated phosphate in patients with CKD who are not on dialysis.
When do patients usually take Renvela?
Renvela is typically taken with meals to help prevent dietary phosphate from being absorbed. The specific dosing schedule depends on the patient’s prescribed regimen and lab results (phosphate levels).
What are common alternatives if Renvela isn’t a fit?
Other phosphate binders may be used instead of sevelamer depending on patient factors such as tolerance, pill burden, calcium or iron status, and clinician preference. These can include calcium-based binders, lanthanum, or iron-based options.
Where can I find official details on Renvela 800 mg?
For drug-specific prescribing information, approvals, and patent-related coverage, DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/